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Prenatal infectionPrenatal lipopolysaccharide (LPS) exposure causes reproductive, behavioral and neurochemical defects in
both dams and pups. The present study evaluated male rats prenatally treated with LPS for behavioral and
neurological effects related to the olfactory system, which is the main sensorial path in rodents. Pregnant
Wistar rats received 100 μg/kg of LPS intraperitoneally (i.p.) on gestational day (GD) 9.5, and maternal
behavior was evaluated. Pups were evaluated for (1) maternal odor preference, (2) aversion to cat odor, (3)
monoamine levels and turnover in the olfactory bulb (OB) and (4) protein expression (via immunoblotting)
within the OB dopaminergic system and glial cells. Results showed that prenatal LPS exposure impaired
maternal preference and cat odor aversion and decreased dopamine (DA) levels in the OB. This dopaminergic
impairment may have been due to defects in another brain area given that protein expression of the ﬁrst
enzyme in the DA biosynthetic pathway was unchanged in the OB. Moreover, there was no change in the
protein expression of the DA receptors. The fact that the number of astrocytes andmicroglia was not increased
suggests that prenatal LPS did not induce neuroinﬂammation in the OB. Furthermore, given that maternal care
was not impaired, abnormalities in the offspring were not the result of reduced maternal care.School of Veterinary Medicine,
s de Paiva, 87, São Paulo, SP
1 3091 7829.
lsevier OA license.© 2011 Elsevier Inc. Open access under the Elsevier OA license.1. Introduction
Prenatal viral and bacterial infections impair short- and long-term
behavior and central nervous system activity of animals [1–3].
Speciﬁcally, previous investigations by our group have shown that
prenatal treatment with lipopolysaccharide (LPS) (100 μg/kg, intra-
peritoneally [i.p.]), which mimics bacterial infections, on gestational
day (GD) 9.5 in rats, reduces male offspring social behavior in infancy
and adulthood, as well as open ﬁeld general activity after a LPS
challenge [4,5]. Moreover, prenatal LPS decreases striatal dopamine
(DA) and metabolite levels [4]. The immunological system is also
affected, as evidenced by an attenuated response to experimentally
induced asthma [44].
It has been suggested that the effects of maternal LPS exposure on
the developing fetal brain are mediated by cytokine induction within
thematernal circulation and placenta [6–9]. Prenatal LPS exposure has
been shown to increase the levels of both cytokines and glucocorti-
coids in the fetal brain [10,11].Infections associated with immunological events in early/middle
fetal life (e.g., GD 8–10 in rats and mice) might have a stronger
neurodevelopmental impact than late-pregnancy infections. Maternal
immune activation during early/middle pregnancymay interfere with
cell proliferation, differentiation, migration, target selection, and
synapse maturation, eventually leading to multiple brain and
behavioral abnormalities in adulthood [12–15].
Prenatal infections also modify animal sensory systems. For
example, prenatal LPS or polyriboinosinic–polyribocytidylic acid
(polyI:C; which mimics viral infections) exposure in rodents impairs
the ability of animals to “gate out” sensory and cognitive information,
with a disrupted prepulse inhibition of the acoustic startle reﬂex
[16,17].
Although there have been studies investigating the links between
prenatal infections and sensory system impairments, the role of
prenatal infections in the olfactory system has not yet been
elucidated. The aim of the present study was therefore to evaluate
behavioral and neurological properties related to the olfactory system
in male rats prenatally treated with LPS. The olfactory system was
chosen for this investigation for several reasons. First, it is the main
sensorial path of rodents, which is virtually blind compared to
humans [18]. Second, the dopaminergic system of the olfactory bulb
(OB) is necessary for the processing of odorant information from
olfactory receptor neurons [19]. Third, the dopaminergic system,
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control of rewarded/punished behaviors [20–22]. Additionally, an
acute LPS administration affects the olfactory dopamine system in
adult mice [23]. For these reasons, we investigated LPS-treated pups
for (1) maternal odor preference, (2) aversion to cat odor, (3)
monoamine levels and turnover in the OB and (4) protein expression
(via immunoblotting) within the OB dopaminergic system and glial
cells. Maternal behavior was also investigated to exclude the
possibility that altered maternal care could be responsible for the
behavioral and neurological impairments observed in their offspring
[24–26].
2. Material and methods
2.1. Animals
Thirty-two pregnant Wistar rats with 12–13 weeks of age,
weighing 216–263 g each, were used (GD 0 deﬁned as when
spermatozoa were detected in the vaginal smear). Dams were
individually housed in polypropylene cages (38×32×16 cm) at
controlled temperature (22±2 °C), humidity (65–70%), and artiﬁcial
lighting (12-hour light/12-hour dark cycle, lights on at 6:00 AM).
Animals had free access to Nuvilab® rodent chow (Nuvital Co., São
Paulo, SP, Brazil) and ﬁltered water. Sterilized and residue-free wood
shavings were used as animal bedding. Animals were distributed into
control and experimental (LPS-treated) groups (n=8 dams/group for
maternal behavior and n=1 pup/litter, 8 pups total for each offspring
study). Dams were allowed to give birth and nurture their offspring
normally. The day of birth was considered as post-natal day (PND) 1.
No handling was performed on PND 1, but on PND 2, 8 offspring (4
males and 4 females) were randomly selected. No cross-fostering
procedure was used. Litters with fewer than 8 pups were culled. The
8 pups were kept with each dam until weaning (PND 21). On PND 21,
littermates were separated, co-housed by sex and in the same
laboratory conditions as their parents. One male pup from each litter
was used for each experiment; the female offspring was separated to
be used in other experiments. All experiments were performed
between 8:00 and 11:00 AM, and control and LPS-treated rats were
tested intermixed. The animals used in this study were kept in
accordance with the guidelines of the Committee on Care and Use of
Laboratory Animal Resources of the School of Veterinary Medicine,
University of São Paulo, Brazil (protocol No. 1398/2008, FMVZ— USP).
These guidelines are similar to those of the National Institutes of
Health, Bethesda, MD. Experiments were carried out in accordance
with the good laboratory practice protocols and with quality
assurance methods.
2.2. Treatment
LPS (from Escherichia coli, Sigma®, serotype 0127: B8) was
dissolved in sterile saline (50 μg/ml LPS in a 0.9% NaCl solution) and
administered i.p. to pregnant rats at a dose of 100 μg/kg on GD 9.5.
This dose was chosen because it has been reported to (1) elicit
sickness behavior in dams, (2) induce endocrine alterations, (3)
increase cytokines at the placental level, and (4) impair offspring
viability and reduce the social behavior of male offspring during
infancy and adulthood [5,27,28]. The control group consisted of
pregnant rats submitted to the same treatment schedule but receiving
sterile saline (0.9% NaCl) only. Each control dam was treated with
0.1 ml/100 g saline solution.
2.3. Maternal behavior
Maternal behavior testing was performed on PND 5. Pups were
removed from the dam at 8:00 AM and placed in another cage away
from their mother. Immediately following the separation, thepresence of a nest in the home cage was evaluated. Sixty minutes
following maternal separation, all pups were returned to the cage of
their mother, and the maternal behavior testing began. The retrieval
of the ﬁrst pup (time, s), the retrieval of all pups (s), grouping (s),
crouching (s) and full maternal behavior (s) were scored [29–31].
Dams were scored as displaying full maternal behavior if they
retrieved all pups to the nest and displayed nursing behavior with
their back arched over the pups for 3 consecutive minutes. If animals
were not scored as displaying full maternal behavior following 30 min
of continuous observation, they were checked every 15 min for
60 min and then hourly thereafter until full maternal behavior was
observed. Events observed following the ﬁrst 30 min of continuous
observation were recorded at the time of the ﬁrst observation (e.g. if
full maternal behavior was ﬁrst observed at 60 min, the full maternal
behavior latency was scored as 60 min). The same criterion was used
for all maternal responses.
2.4. Maternal odor preference test
Maternal odor preference testing was performed on PND 7 as
described elsewhere [32]. Brieﬂy, one male pup from each exper-
imental and control litter (n=8 for each groups) was examined. The
test design was based on studies of associative olfactory learning and
consisted of a two-odor choice between areas with nest material or
fresh bedding. A polypropylene cage (38×32×16 cm) divided in half
by a 2-cm wide neutral zone running the length of the box was used.
In each area, 300 mL of fresh or nest bedding was placed in adjacent
corners. The pup was placed in the 2-cm neutral zone at the end of the
box facing the opposite target beddings. During the 1-min trial, the
amount of time the pup (the head or the whole body) spent in each of
the two areas was recorded. Animals were tested in ﬁve trials with an
inter-test interval of 2 min during which the pup was placed in the
home cage. In each trial, beddings were switched between the sides of
the box. Following each test period, the box was cleaned with 5%
ethanol to remove trace odors. Experiments were recorded with a
video camera for later analysis. The pups' total time in each area was
obtained by combining the times from the ﬁve trials.
2.5. Aversive exposure to cat odor test
One prenatally LPS-treated and control (un-treated) adult (PND
60) male rat from each litter (n=8 for both groups) was used to
evaluate the effects of cat odor exposure, which is an aversive
olfactory stimuli. Moreover, another eight rats without any treatment
were used as neutral group, not exposed to cat odor.
Cat odor was obtained by rubbing a damp cloth (18×22 cm)
vigorously against the fur of a domestic female adult cat for 5 min.
This procedure was carried out 1 h prior to the experimental session.
The cat odor clothwas kept in a sealed plastic bag. Each clothwas used
for four exposures only. Damp pieces from the original cloth, not
rubbed on the cat, were used for the neutral odor. All odor exposures
took place in a separate, small, dimly lit room, and neutral odor
exposures always preceded the cat odor exposures in order to prevent
any traces of cat odor inﬂuencing the neutral odor group. Prior to the
ﬁrst cat odor exposure, the cloth with cat odor was left in the test
room for 10 min. Each rat was carried to the exposure room in a
home-cage that was placed next to the odor cloth wedged between
the cage tops. The cloth was placed at the opposite end from the food
and water containers. The duration of the test was 5 min, and the rats
were videotaped for later scoring. The number and the time (s) of
cloth contact were deﬁned as direct contact or snifﬁng ≤5 cm from
the cloth. The number of sheltering events and the duration (s) of
sheltering were deﬁned as when the rat was underneath the food and
water compartments. For further details, see Zangrossi and File 1992
and Andrews et al. 1993 [33,34].
Table 1
Effects of LPS exposure (100 μg/kg on GD 9.5) on maternal behavior in rats on PND 5
(n=8 for both groups, data presented as means±SEMs).
Parameters Control group LPS group p
1st pup retrieval(s) 30.88±6.60 12.75±4.34⁎ 0.0377
2nd pup retrieval(s) 51.38±5.74 76.75±24.78 0.3355
3rd pup retrieval(s) 70.25±6.55 89.63±24.55 0.4584
4th pup retrieval(s) 112.38±13.68 121.25±30.23 0.7930
5th pup retrieval(s) 202.50±40.88 155.00±27.28 0.3502
6th pup retrieval(s) 350.63±63.47 216.00±49.36 0.1162
7th pup retrieval(s) 424.13±64.07 274.75±51.80 0.0913
8th pup retrieval(s) 536.88±82.80 478.25±133.00 0.7139
Grouping(s) 544.38±90.98 509.75±51.11 0.7450
Crouching(s) 936.50±53.95 809.38±76.13 0.1946
Full maternal behavior(s) 1346.88±48.88 1320.13±125.00 0.8449
Nest presence 8/8 7/8 –
45 min 7/8 7/8 –
60 min 7/8 7/8 –
⁎ pb0.05 versus the control group (Student's t-test).
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bulb
On PND 60, male rats prenatally treatedwith LPS or controls (n=8
for both groups) were decapitated. Brains were rapidly dissected on
dry ice and prepared as described previously [35]. Brieﬂy, the OB was
dissected, weighed, and stored at −80 °C until used for further
analyses. Following sample collection, tissue was placed in a
perchloric acid solution and homogenized by sonication for the
immediate determination of neurotransmitter and metabolites levels.
DA and its metabolites (3,4-dihydroxyphenylacetic acid [DOPAC], and
homovanillic acid [HVA]), serotonin (5-HT) and its metabolite 5-
hydroxyindolacetic acid (5HIAA) and norepinephrine (NOR) were
measured by high-pressure liquid chromatography (HPLC) (Shi-
madzu, model 6A, Kyoto, Japan) using a C-18 column (Shimpak,
ODS, Kyoto, Japan), an electrochemical detector (model 6A, Shimadzu,
Kyoto, Japan), a sample injector (15 and 20 Al valve), and an
integrator (Chromatopac, Shimatzu, Kyoto, Japan). DA and 5-HT
turnover (metabolite/neurotransmitter ratio) were also evaluated.
Each sample was run for 18 min. The detection limit for DA, DOPAC,
HVA, 5-HT, 5HIAA and NOR was 2 pg. Recovery values were higher
than 80% for all substances, the coefﬁcients of variation were less than
15%, and the curve linearities were greater than 0.9.
2.7. Immunoblotting in the olfactory bulb
Protein expression was analyzed as described elsewhere [36].
Brieﬂy, male rats prenatally treated with LPS or controls (n=6–8 for
both groups) were decapitated at PND 60 and the OB were rapidly
collected and homogenized in an extraction buffer. Homogenates
were subjected to centrifugation and the protein concentration of the
supernatant was determined using a protein assay (Bio-Rad®,
Hercules, CA, USA). Samples from the homogenate containing 75–
100 μg protein were run on an acrylamide gel and electrotransferred
to nitrocellulose membranes using a Trans-Blot cell system (Bio-
Rad®, Hercules, CA, USA). Nitrocellulose membranes were then
blocked and incubated with the following primary antibodies:
mouse anti-tyrosine hydroxylase (TH) monoclonal antibody, mouse
anti-dopamine D1a receptor monoclonal antibody, rabbit anti-human
dopamine receptor D2 polyclonal antibody (Chemicon®, Temecula,
CA, USA), mouse anti-glial ﬁbrillary acidic protein (GFAP) monoclonal
antibody to mark astrocytes (Sigma®, St. Louis, MO, USA) and mouse
anti-rat CD11b/cmonoclonal (OX-42) to markmicroglia (Pharmingen
BD Biosciences®, CA, USA). A loading control of β-actin was used in all
experiments with an anti-β-actin antibody (Sigma®, St. Louis, MO,
USA). Bound antibodies were visualized using a chemiluminescence
kit (ECL Kit; Amersham Biosciences®, Little Chalfont, Buckingham-
shire, United Kingdom). Lastly, blots were densitometrically analyzed
using Scion Image 4.0.2 software (Scion Corporation®, Frederick, MD,
USA). Because there were no changes in the expression levels of β-
actin under our conditions, the optical densities of TH, D1a, D2, GFAP
and OX-42 bands were ﬁrst normalized in relation to the correspond-
ing β-actin bands in each experiment. Normalized data were
subsequently analyzed for changes in protein expression levels in
the LPS-treated OB compared to controls for each time point.
2.8. Statistical analyses
Results were expressed as means±SEMs. One male rat pup from
each dam (used as a unit) was considered in the offspring studies to
avoid litter effects. Homoscedasticity was veriﬁed through the F or
Bartlett's test. Normality was veriﬁed through the Kolmogorov–
Smirnov test. The Student's t-test (unpaired, two-tailed) was used to
compare the parametric group data. For the cat odor aversion test, a
one-way analysis of variants (ANOVA) followed by the Tukey test was
used. In all cases, results were considered signiﬁcant if pb0.05.3. Results
Dams from the LPS-treated group retrieved the ﬁrst pup faster
than the controls. However, LPS exposure did not affect any other
aspect of maternal behavior, i.e., the retrieval of all other pups,
grouping, crouching, full maternal behavior and nest presence
(Table 1). Thus, maternal behavior was slightly improved in pregnant
rats treated with LPS on GD 9.5.
As depicted in Fig. 1, prenatal treatment with LPS impaired
maternal odor preference. Prenatally treated pups spent less time
over the nest material than controls in the third and fourth trials and
less total time, summed over of the ﬁve trials.
As depicted in Fig. 2, prenatal treatmentwith LPS also impaired the
aversive response of adult rats to cat odor. The time in contact with
the cloth was reduced in controls, but not in the LPS group, when
compared with neutral odor group. The control group and the LPS-
treated group showed a reduced number of cloth contacts when
compared to the neutral odor group. The number of sheltering events
and the time of sheltering were not different between neutral odor,
control and LPS-treated groups (number of sheltering events: neutral
odor group=4.87± 0.48, control group=4.87±0.81, LPS
group=5.50±0.42, p=0.6978; time of sheltering: neutral
group=85.25±18.16, control group=140.10±15.76, LPS
group=120.30±13.04, p=0.0663).
The OB monoamine and metabolite levels and turnover rates are
shown in Table 2. Adult male pups prenatally treated with LPS
presented a reduction in OB DA levels with respect to the control
group. However, no differences in the levels of DOPAC, HVA, 5-HT,
5HIAA, NOR, or in the DOPAC/DA, HVA/DA, and 5HIAA/5-HT ratios,
were observed in the OB of the LPS-treated group when compared
with controls.
Olfactory bulb protein expression levels are shown in Table 3. No
differences in TH, D1a, D2, GFAP and OX-42 expression levels were
found between LPS-treated and control groups.
4. Discussion
The present study shows that prenatal LPS exposure impairs
behaviors and neurochemical properties related to olfaction. These
impairments were not induced by a decrease in maternal care, which
was essentially unchanged. Dams treated with LPS, in fact, were more
motivated to retrieve the ﬁrst pup following separation. Consequent-
ly, pups of dams treated with LPS received the same or even more
attention from their mothers compared to controls. The impairments
shown by the pups, therefore, were likely due to actions of maternal
immunological mediators released following prenatal LPS exposure,
particularly proinﬂammatory cytokines within the maternal
Fig. 1. Effects of prenatal LPS exposure (100 μg/kg on GD 9.5) on time spent over nest
bedding area in the maternal odor preference test in infant male rat pups on PND 7.
Gray bars = control group; black bars = LPS group. n=8 pups/group. * pb0.05 and **
pb0.01 (Student's t test) compared with the control group. Values are represented as
means±SEM.
Table 2
Effects of prenatal LPS exposure (100 μg/kg on GD 9.5) on OB DA and metabolite levels
(ng/g) and turnover rates in adult male rats on PND 60 (n=8 for both groups, data
presented as means±SEMs).
Parameters Control group LPS group p
DA 157.25±16.98 85.79±10.74⁎⁎ 0.0032
DOPAC 21.20±2.87 15.32±3.84 0.2399
HVA 12.28±1.44 8.43±2.13 0.1567
DA+DOPAC+HVA 190.73±19.86 109.54±13.40⁎⁎ 0.0044
DOPAC/DA 0.14±0.01 0.17±0.03 0.3572
HVA/DA 0.08±0.01 0.10±0.02 0.3754
5-HT 128.57±5.10 106.64±13.74 0.1568
5HIAA 137.66±5.75 114.29±15.20 0.1726
5HIAA/5-HT 1.08±0.06 1.09±0.08 0.9079
NOR 12.89±1.51 11.98±1.83 0.7069
⁎⁎ pb0.01 versus the control group (Student's t-test).
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detected in the fetal brain [7–10].
Infant rats prenatally treated with LPS presented impairment in
the maternal odor preference test, spending less time over nest
material. These data represent a strict impairment in olfaction
because rats have their eyes closed on PND 7 and olfaction is the
ﬁrst sensory system to become functional [18,37].
Prenatal LPS also reduced the cat aversion response in adulthood.
LPS prenatally treated rats spent statistically the same amount of time
in contact with the cloth with cat odor as the neutral odor group spent
in contact with the neutral odor cloth. However, rats in the control
(untreated) group reduced the time spent with the clothwith cat odor
when compared to the neutral odor group. Aversion to cat odor
represents an instinctive, response to the odor of a natural predator
[33]. In other words, rats prenatally exposed to LPS did not respond to
cat odor as an aversive stimulus. Moreover, the rat olfactory system
was impaired both in infancy and adulthood, suggesting that prenatal
LPS exposure induced a long-lasting impairment in olfactory function.
Cat odor exposure is a test of anxiety. Normally, rats display
anxiogenic responses during a cat odor exposure, such as a decreased
contact with the cat odor cloth without habituation after several trials
[33]. However, treated rats did not present decreased contact with the
cat odor, i.e., they did not display these anxiety-related behaviors. At
ﬁrst, apparently prenatal treatment with LPS disrupted anxiety
mechanisms. Indeed, in our previous study, prenatal LPS did not
changed anxiety parameters in relation to controls when evaluated by
activity on the elevated plus maze, which is currently the most
popular test of anxiety [5]. Thus, based on maternal odor preference
test and determination of monoamine levels and turnover in the OB
ﬁndings, we believe that an olfactory defect is responsible for the lack
of an anxiety response in this model.Fig. 2. Effects of prenatal LPS exposure (100 μg/kg on GD 9.5) on aversion to cat odor in a
followed by the Tukey test) compared with the neutral odor group. Values are representedThe impairment to respond to an attractive olfactory stimulus
(maternal odor) and an aversive olfactory stimulus (cat odor) in rats
prenatally treated with LPS could be a result of motor impairments.
However, our previous study indicated that these animals have
normal motor activity when evaluated for reﬂexological develop-
ment, open ﬁeld general activity in infancy and adulthood, catalepsy
induced by haloperidol and stereotyped behavior induced by
apomorphine [4].
The behavioral indications of olfactory impairments in infant and
adult rats prenatally treated with LPS can be explained by decreased
DA levels in the OB. This result also reinforces the idea that the
olfactory system is impaired in these rats. Moreover, DA plays an
important role on olfaction [38,39]. However, besides the observed
decrease in DA levels in the LPS-treated group, themetabolite (DOPAC
and HVA) levels, as well as the metabolite/neurotransmitter ratio (DA
turnover) were not modiﬁed. The fact that the turnover of DA was not
altered, suggests that dopaminergic system activity was normal in the
OB. In addition to decreased DA, the total values of DA and the
metabolites (DA+DOPAC+HVA) were also decreased, showing that
the DA decrease is the critical factor involved with the olfactory
impairment. In other words, the rate of synthesis and degradationwas
not modiﬁed, although the level of the neurotransmitter was lower.
Furthermore, protein expression of the ﬁrst enzyme in the DA
biosynthetic pathway, TH, and the dopamine receptors D1a, and D2
were unchanged in the OB. According to Cave and Baker [19], the
expression of TH in the OB is restricted to the glomerular layer, where
DA interneurons are found. Thus, DA production by DA interneurons
in the OB may not be altered. This being the case, the reduced DA
levels found in the OB may not be a consequence of dopaminergic
impairment in the OB itself but of dopaminergic impairment in
afferent ﬁbers from the olfactory DA system and/or in another brain
area, such as subventricular zone andmesolimbocortical system.With
respect to this ﬁnding, previous analyses by our group demonstrated
that prenatal exposure to LPS reduces DA, metabolites levels [4] anddult male rats at PND 60. n=8/group. ** pb0.01 and *** pb0.0001 (one-way ANOVA
as means±SEM.
Table 3
Effects of prenatal LPS exposure (100 μg/kg on GD 9.5) on OB protein expressions
(normalized optical density/β-actin ratio) in adult male rats on PND 60 (n=6–8 for
both the groups, data presented as means±SEMs).
Protein Control group LPS group p
TH 1.00±0.12 0.87±0.13 0.5380
D1 1.00±0.08 0.99±0.22 0.9805
D2 1.00±0.15 0.74±0.09 0.1106
GFAP 1.00±0.09 1.00±0.14 0.9879
OX-42 1.00±0.12 1.09±0.11 0.6162
Student's t-test.
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reduces TH expression in the mouse substantia nigra [40]. Moreover,
in an animal model of Parkinson's disease, the ablation of dopami-
nergic inputs caused by the death of dopaminergic neurons in the
substantia nigra resulted in decreased proliferation and loss of TH
immunoreactivity in the subventricular zone [41]. Though it is
tempting to speculate that these regions are related to the decreased
DA levels observed in the OB, we will investigate this regions in our
model of prenatal infection in future studies.
Astrocytes andmicroglia are glial cells that increase in number and
become activated following an infection or an immunological
challenge, such as an acute administration of LPS [42]. Importantly,
astrocytes and glia were not increased in prenatally LPS-treated rats,
suggesting that there was no neuroinﬂammation in the OB of adult
rats.
Another explanation for the present ﬁndings besides the olfaction
impairment is that rats prenatally treated with LPS have impaired
motivation. Supporting evidence for this hypothesis comes from the
ﬁnding that prenatal exposure to LPS impaired the social interest of
rats in infancy and adulthood due to motivational impairments [5].
This behavioral change cannot be attributed to motor impairments as
the motor activity of these animals is normal [4]. For these reasons,
and because maternal and cat olfactory stimuli are linked to a rat's
survival and are therefore difﬁcult to ignore, we accept the reduced
motivational hypothesis. Furthermore, it is known that in addition to
its involvement in motor control, DA is also involved in motivation
[43]. The present data showing decreased DA levels is therefore
consistent with motivational impairments in rats prenatally exposed
to LPS.5. Conclusions
In conclusion, prenatal LPS exposure impaired maternal prefer-
ence and aversion to cat olfactory cues and decreased DA levels in the
OB. This dopaminergic impairment may involve other brain areas as
we found that TH expression was unchanged in the OB. Moreover, the
expression of astrocytes and microglia was not altered, suggesting
that there was no neuroinﬂammation in the OB. Furthermore,
maternal care was not impaired, indicating that the defects observed
in the offspring were not the result of reduced maternal care.Conﬂicts of interest
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